Physician recommendations trump patient preferences in prostate cancer treatment decisions

Medical Decision Making

Volumn 37, Issue 1, 2017, Pages 56-69

  Scherr, Karen A ^a   Fagerlin, Angela ^b,h   Hofer, Timothy ^b   Scherer, Laura D ^c   Holmes Rovner, Margaret ^d   Williamson, Lillie D ^a,i   Kahn, Valerie C ^e   Montgomery, Jeffrey S ^e   Greene, Kirsten L ^f   Zhang, Biqi ^g,j   Ubel, Peter A ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Hierarchical models; Logistic regression models; Physician patient communication; Prostate cancer; Qualitative methods; Shared decision making; Urology

Indexed keywords

AGE; AGED; ANXIETY; CANCER GRADING; COITUS; DECISION MAKING; DOCTOR PATIENT RELATION; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; PHYSICIAN; PROSTATE TUMOR; PSYCHOLOGY;

AGE FACTORS; AGED; ANXIETY; COITUS; COMMUNICATION; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PATIENT PARTICIPATION; PATIENT PREFERENCE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PROSTATIC NEOPLASMS;

EID: 85014343985     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X16662841     Document Type: Article

References (34)

1. Keirns C, Goold SD. Patient-centered care and preference-sensitive ecision making. JAMA. 2009;302(16):1805-6.
2. Sidana A, Hernandez D, Feng Z, et al. Treatment decision-making for localized prostate cancer: What younger men choose and why. Prostate. 2012;72(1):58-64.
3. Johansson E, Steineck G, Holmberg L, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011;12(9):891-9.
4. Thompson I, Thrasher J, Aus G, et al.; AUA Prostate Cancer Clinical Guideline Update Panel. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106-31.
5. Barry M, Edgman-Levitan P. Shared decision making - the pinnacle of patient-centered care. N Engl J Med. 2012;366:780-1.
6. Mulley A, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients' preferences matter. BMJ. 2012;345:1-6.
7. Davison B, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012;3:369-374.
8. Gwede C, Pow-Sang J, Seigne J, et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005;104(7):1381-90.
9. Hall J, Boyd J, Lippert M, Theodorescu D. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology. 2003;61(2):402-7.
10. Steginga S, Occhipinti S, Gardiner R, Yaxley J, Heathcote P. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology. 2004;63:751-6.
11. Song L, Chen R, Bensen J, et al. Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician? Cancer. 2013;119(2):421-8.
12. Diefenbach M, Dorsey J, Uzzo R, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002;20(1):55-62.
13. Berry D, Ellis W, Woods N, Schwien C, Mullen K, Yang C. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003;21:93-100.
14. Veterans Affairs Office of Research and Development. Testing the helpfulness of 2 decision aids for prostate cancer. ClinicalTrials.gov. 2007. NLM Identifier: NCT00432601. Available from: URL: http://clinicaltrials.gov/show/NCT00432601. Accessed 16 June 2016.
15. Roth AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: Validation of a new scale to measure anxiety in men with prostate cancer. Cancer. 2003;97(11):2910-8.
16. Scherr KA, Fagerlin A, Williamson LD, et al. The Physician Recommendation Coding System (PhyReCS): a reliable and valid method to quantify the strength of physician recommendations during clinical encounters. Med Decis Making. In press.
17. Hsieh H, Shannon S. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88.
18. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-6.
19. Long JS. Regression Models for Categorical Dependent Variables Using Stata. College Station (TX): Stata Press; 2014.
20. StataCorp. Structural Equation Modeling Reference Manual. College Station (TX): Stata Press; 2013.
21. Ubel PA. Medical facts versus value judgments - toward preference-sensitive guidelines. N Engl J Med. 2015;372(26):2475-7.
22. Pierorazio P, Walsh P, Partin A, Epstein J. Prognostic Gleason grade grouping: data based on the modified Gleason schoring system. BJU Int. 2013;111(5):753-60.
23. Sommers B, Beard C, D'Amico A, et al. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer. 2007;110(10):2210-7.
24. Frongillo M, Feibelmann S, Belkora J, Lee C, Sepucha K. Is there shared decision making when the provider makes a recommendation? Patient Educ Couns. 2013;90(1):69-73.
25. Ubel PA, Angott AM, Zikmund-Fisher BJ. Physicians recommend different treatments for patients than they would choose for themselves. Arch Intern Med. 2011;171(7):630-4.
26. Ubel PA. Critical Decisions. New York: Harper Collins; 2012.
27. Hoffman KE, Niu J, Shen Y, et al. Physician variation in management of low-risk prostate cancer. JAMA Intern Med. 2014;174(9):1450-9.
28. Holmes-Rovner M, Montgomery J, Rovner D, et al. Informed decision making: assessment of the quality of physician communication about prostate cancer diagnosis and treatment. Med Decis Making. 2015;35(8):999-1009.
29. National Comprehensive Cancer Network, American Cancer Society. Prostate Cancer: Treatment Guidelines for Patients. Fort Washington (PA): National Comprehensive Cancer Network; 2007.
30. Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370:932-42.
31. Wilt T, Brawer M, Jones K, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203-13.
32. Oliver A. The Veterans Health administration: an American success story? Milbank Q. 2007;85(1):5-35.
33. Feldman L, Skeel-Williams K, Knox M, Coates J. Influencing controlled substance prescribing: Attending and resident physician use of a state prescription monitoring program. Pain Med. 2012;13:908-14.
34. Roter D, Hall J. Physician gender and patient-centered communication: a critical review of empirical research. Annu Rev Public Health. 2004;25:497-519.